Protalix BioTherapeutics
PLX
#8588
Rank
C$0.16 B
Marketcap
$2.29
Share price
-2.96%
Change (1 day)
20.02%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$87.89 Million

According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are C$87.89 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$67.46 M-25.15%
2022-12-31C$90.13 M-11.26%
2021-12-31C$0.10 B-16.12%
2020-12-31C$0.12 B-19.87%
2019-12-31C$0.15 B-2.69%
2018-12-31C$0.15 B21.5%
2017-12-31C$0.12 B3.16%
2016-12-31C$0.12 B3.41%
2015-12-31C$0.11 B-22.92%
2014-12-31C$0.15 B4.1%
2013-12-31C$0.14 B82.94%
2012-12-31C$81.62 M3.03%
2011-12-31C$79.22 M4.21%
2010-12-31C$76.02 M-12.73%
2009-12-31C$87.1 M1008.32%
2008-12-31C$7.85 M76.97%
2007-12-31C$4.44 M41.07%
2006-12-31C$3.14 M139.3%
2005-12-31C$1.31 M1442.72%
2004-12-31C$0.08 M-16.6%
2003-12-31C$0.1 M-18.13%
2002-12-31C$0.12 M1.45%
2001-12-31C$0.12 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$0.84 B 865.28%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.13 B 1,196.24%๐Ÿ‡บ๐Ÿ‡ธ USA
C$177.19 B 201,488.34%๐Ÿ‡บ๐Ÿ‡ธ USA
C$49.38 B 56,085.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel